RT @NEJM
Maternal vaccination was 82% effective in preventing medically attended RSV-associated lower respiratory tract illness in infants within 90 days after birth and 69% effective within 180 days. Full results of the MATISSE trial: https://nej.md/3Mc1hmg

#InfectiousDisease